Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

845.67 +5.80 (+0.69%)
Streaming Delayed Price Updated: 3:24 PM EDT, Oct 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Eli Lilly Eyes India For Manufacturing, Plans To Spend $1 Billion
Eli Lilly plans over $1 billion investment in India to expand drug manufacturing, partnerships, and a new Hyderabad facility. 
Via Benzinga
Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma Giants
Trump’s drug price plan drove a Pfizer rally, leaves Eli Lilly buffered by U.S. investments, and could boost JNJ if it secures similar tariff relief. 
Via MarketBeat
Topics Government Supply Chain World Trade
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Breakthrough in Alzheimer’s Diagnostics: University of Liverpool Unveils Low-Cost, Handheld AI Blood Test
In a monumental stride towards democratizing global healthcare, researchers at the University of Liverpool have announced the development of a pioneering low-cost, handheld, AI-powered blood test... 
Via TokenRing AI
Topics Artificial Intelligence
Eli Lilly Bets Big On India With $1B Investment To Boost Mounjaro, Drug Manufacturing Network
Via Stocktwits
Viking Therapeutics Ignites Retail-Trader Frenzy Amid Deal Speculation, Upcoming Trial Catalysts
Via Stocktwits
Eli Lilly: Beyond Weight Loss
Eli Lilly is riding a big trend. 
Via The Motley Fool
The Healthcare Stock Play That Could Make Millennials Rich
This investment may also make baby boomers, and those from Gen X and Gen Z, rich as well. 
Via The Motley Fool
Topics ETFs
2 Beaten-Down Stocks Primed for a Comeback
The market is sleeping on these stocks, but you don't have to. 
Via The Motley Fool
Viking Therapeutics Stock: A Stumble Or The Setup Of The Decade?
Viking Therapeutics is not a household name yet. But this small biotech is trying to play in the biggest money game in healthcare right now: weight loss drugs. The same field where Novo Nordisk and Eli... 
Via Talk Markets
Navigating the Storm: Essential Strategies to Avoid 'Bag Holder' Status in Volatile Markets
The financial markets, as of October 4, 2025, continue to be characterized by a significant degree of volatility, presenting both opportunities and perilous traps for investors. In such an environment,... 
Via MarketMinute
Topics ETFs Economy
Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors
As of October 2025, the global financial markets are undergoing a profound transformation, driven by an accelerating wave of technological innovation and a pressing global imperative for... 
Via MarketMinute
Topics Artificial Intelligence Climate Change Economy
Market Defies D.C. Gridlock: S&P 500 and Dow Jones Soar to Record Highs Amidst Government Shutdown
The U.S. financial markets are currently presenting a perplexing paradox. As of October 4, 2025, both the S&P 500 and Dow Jones Industrial Average (DJIA) have surged to unprecedented record highs,... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
4 Reasons to Buy Amgen Stock Right Now
For those with a sufficiently long investment horizon, the stock looks attractive. 
Via The Motley Fool
Topics Intellectual Property
Wall Street Hits Record Highs As Rate Cut Bets Offset Shutdown: This Week In Markets
S&P500, Nasdaq100, Dow Jones, and Russell 2000 all hit record highs as investors focus on corporate optimism, monetary easing and AI tech. 
Via Benzinga
Topics Artificial Intelligence Stocks
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Danish Equities Soar as OMX Copenhagen 20 Posts Strong Gains Amidst Bullish Market Sentiment
Copenhagen's stock market demonstrated robust performance in early October 2025, with the benchmark OMX Copenhagen 20 (OMXC20) index experiencing a significant uplift. While specific daily fluctuations... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Why Shares of Eli Lilly Soared This Week
Pfizer's deal with the Trump administration raised hopes that Eli Lilly would also avoid pharmaceutical tariffs. 
Via The Motley Fool
Topics Government World Trade
Eli Lilly And Its Competitors Pop On The Pfizer News
Eli Lilly and other US-based drug makers have led the market over the last few days. 
Via Talk Markets
Spotlight on Eli Lilly: Analyzing the Surge in Options Activity
 
Via Benzinga
Eli Lilly Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)
 
Via Benzinga
My 6 Top-Ranked Stocks to Buy Now in October (2025)!
This excellent list of stocks includes growth stocks, AI stocks, and dividend stocks. 
Via The Motley Fool
Topics Artificial Intelligence
Federal Shutdown Paralysis: Data Delays Deepen Economic Damage Fears
The United States economy finds itself navigating treacherous waters as a federal government shutdown grips the nation, sparking heightened concerns about widespread economic damage. What makes this... 
Via MarketMinute
Topics Economy Initial Public Offering Regulatory Compliance
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Novo Nordisk (NVO) Soars as HSBC Upgrades to "Buy," Citing Strategic Focus and Pipeline Strength
Copenhagen, Denmark – October 2, 2025 – Shares of Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) experienced a significant surge yesterday, October 1, 2025, following a pivotal upgrade from HSBC.... 
Via MarketMinute
Topics Economy
Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. 
Via StockStory
Topics Government World Trade
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. 
Via StockStory
Topics World Trade
These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap
Health care stocks are rallying, but Pfizer, Merck and Bristol-Myers still trade below 10x forward P/E — a rare market discount. 
Via Benzinga
Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures
A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human... 
Via MarketMinute
Topics Artificial Intelligence Derivatives
Nanobiotix Stock Soars on Breakthrough Esophageal Cancer Data, Igniting Biotech Hopes
Paris, France – October 2, 2025 – Nanobiotix (NASDAQ: NBTX) witnessed a significant surge in its stock price today, jumping 11.6%, following the announcement of highly encouraging initial data from a... 
Via MarketMinute
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.